Trending
- Breast cancer risk genes affecting individual radiosensitivity
- 68 Breast Cancer Stem Cells and Genomic Drivers of Therapeutic Resistance
- Pirtobrutinib Plus Venetoclax/Rituximab Improves PFS in Pretreated CLL
- SC Mosunetuzumab Exhibits Response Durability in Follicular Lymphoma
- Sonrotoclax Plus Zanubrutinib Achieves >90% uMRD in Treatment-Naive CLL/SLL
- Hepatitis B virus–induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities
- Pirtobrutinib Regimen May Offer Prolonged Remissions in Pretreated CLL
- Favezelimab Combo Boosts PFS vs Chemo in PD-1–Refractory Hodgkin Lymphoma
Monday, June 15